Haoxi Health Technology Limited (HAO)
NASDAQ: HAO · Real-Time Price · USD
1.200
-0.020 (-1.64%)
At close: Oct 27, 2025, 4:00 PM EDT
1.200
0.00 (0.00%)
After-hours: Oct 27, 2025, 4:00 PM EDT
Company Description
Haoxi Health Technology Limited, through its subsidiaries, provides online marketing solutions in China.
It offers online marketing solutions, including online short video marketing solutions to advertisers through its media partners; and customized marketing solutions by planning, producing, placing, and optimizing online ads to help advertisers acquire, convert, and retain consumers on various online media platforms.
The company places its ads through mainstream online short video and social media platforms, such as Toutiao, Douyin, WeChat, and Sina Weibo.
It serves advertiser client base primarily in the healthcare industry. Haoxi Health Technology Limited was founded in 2018 and is based in Chaoyang, China.
Haoxi Health Technology Limited
| Country | China |
| Founded | 2018 |
| IPO Date | Jan 26, 2024 |
| Industry | Advertising Agencies |
| Sector | Communication Services |
| Employees | 26 |
| CEO | Zhen Fan |
Contact Details
Address: Tower C, Building 103, Floor 8, Room 801 Chaoyang China | |
| Phone | 86 10 13311 587976 |
| Website | haoximedia.com |
Stock Details
| Ticker Symbol | HAO |
| Exchange | NASDAQ |
| Share Class | Class A Shares |
| Fiscal Year | July - June |
| Reporting Currency | USD |
| IPO Price | $4.00 |
| CIK Code | 0001954594 |
| CUSIP Number | 73936Q629 |
| ISIN Number | KYG4290F1000 |
| SIC Code | 7311 |
Key Executives
| Name | Position |
|---|---|
| Zhen Fan | Chairman and Chief Executive Officer |
| Lei Xu | Founder, Chief Compliance Officer, Chief Operating Officer and Director |
| Dongxue Li | Chief Financial Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Oct 24, 2025 | 6-K | Report of foreign issuer |
| Oct 20, 2025 | 20-F | Annual and transition report of foreign private issuers |
| Oct 17, 2025 | 6-K | Report of foreign issuer |
| Jun 13, 2025 | EFFECT | Notice of Effectiveness |
| Jun 10, 2025 | F-3/A | Filing |
| Jun 9, 2025 | UPLOAD | Filing |
| May 30, 2025 | F-3 | Filing |
| May 15, 2025 | SCHEDULE 13G/A | Filing |
| Apr 23, 2025 | 6-K | Report of foreign issuer |
| Apr 14, 2025 | 6-K | Report of foreign issuer |